|
|
| | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate Basic information |
| Product Name: | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | | Synonyms: | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate;EOS-60599;TERT-BUTYL N-[(4-BROMO-5-CYANO-1-METHYL-1H-PYRAZOL-3-YL)METHYL]-N-METHYLCARBAMATE;Carbamic acid, N-[(4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl]-N-methyl-, 1,1-dimethylethyl ester;tert-butyl N-[(4-bromo-5-cyano-1-methylpyrazol-3-yl)methyl]-N-methylcarbamate;1-methyl-3-[(N-methyl-N-boc-amino)methyl]-1H-pyrzole-5-methannitrile;ert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | | CAS: | 1454848-24-8 | | MF: | C12H17BrN4O2 | | MW: | 329.19 | | EINECS: | | | Product Categories: | | | Mol File: | 1454848-24-8.mol |  |
| | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate Chemical Properties |
| Boiling point | 441.1±45.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | pka | -1.77±0.70(Predicted) |
| | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate Usage And Synthesis |
| Uses | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate is a pharmaceutical intermediate compound that can be used in the synthetic anticancer prescription drug Lorlatinib. Lorlatinib is a drug used in the treatment of non-small cell lung cancer caused by adult non-small cell lung cancer (NSCLC) caused by an unusual mesenchymal lymphoma. |
| | tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate Preparation Products And Raw materials |
|